ISOCEL

Biopharmaceutical preparations; Biopharmaceutical preparations in the nature of T-cell allogenic therapies; Cell therapies for use in oncology, immunology, and immuno-oncology; Therapeutic agents for targeting tumors; Biological components, namely, genetically engineered T-cells, being a component in therapeutic preparations for use in diseases and disorders of oncology, immunology, and immuno-oncology; Human cells for medical and therapeutic use; T-cells for medical and therapeutic use